Johnson&Johnson (JNJ/NYSE): general review
12 December 2018, 12:43
| Scenario | |
|---|---|
| Timeframe | Intraday |
| Recommendation | BUY STOP |
| Entry Point | 148.00 |
| Take Profit | 151.00, 154.00, 156.00 |
| Stop Loss | 147.00, 145.00 |
| Key Levels | 138.00, 141.00, 144.00, 148.00 |
| Alternative scenario | |
|---|---|
| Recommendation | SELL STOP |
| Entry Point | 143.90 |
| Take Profit | 138.00, 136.00 |
| Stop Loss | 147.00 |
| Key Levels | 138.00, 141.00, 144.00, 148.00 |
Current trend
Johnson & Johnson shares rose by 23.5% from the May 52-week low and are currently trading at a discount of 0.8% to a three-month high. The US Department of Justice ordered the company to pay USD 360 million to the US government in financial aid to a charity for covering Medicare insurance costs to patients.
In the previous week, the stock of Johnson & Johnson grew by 0.20%. S&P500 declined by 5.51% within the same period.
Support and resistance
The emitter continues to consolidate near annual highs. No single direction tendencies are observed. Key support and resistance levels are at 144.00 and 148.00, respectively. In the near future, correction of the company's shares after a protracted growth cannot be excluded.
Indicators don't give a clear signal: the price has consolidated below MA(50) and MA(200), and MACD histogram is located near the zero line. Positions are to be opened from key levels.
Comparing company's multiplier with its competitors in the industry, we can say that #JNJ shares are neutral.
Support levels: 144.00, 141.00, 138.00.
Resistance levels: 148.00.
Trading tips
If the price consolidates above the resistance level of 148.00, one may consider buying the company's stock. Potential profits should be locked in by orders at 151.00, 154.00, and 156.00. Stop loss – 145.00.
If the price consolidates below 144.00, #JNJ shares are expected to correct. The moving potential is aimed at the area of 138.00-136.00. Stop loss – 147.00.
Implementation period: 3 days.
Johnson & Johnson shares rose by 23.5% from the May 52-week low and are currently trading at a discount of 0.8% to a three-month high. The US Department of Justice ordered the company to pay USD 360 million to the US government in financial aid to a charity for covering Medicare insurance costs to patients.
In the previous week, the stock of Johnson & Johnson grew by 0.20%. S&P500 declined by 5.51% within the same period.
Support and resistance
The emitter continues to consolidate near annual highs. No single direction tendencies are observed. Key support and resistance levels are at 144.00 and 148.00, respectively. In the near future, correction of the company's shares after a protracted growth cannot be excluded.
Indicators don't give a clear signal: the price has consolidated below MA(50) and MA(200), and MACD histogram is located near the zero line. Positions are to be opened from key levels.
Comparing company's multiplier with its competitors in the industry, we can say that #JNJ shares are neutral.
Support levels: 144.00, 141.00, 138.00.
Resistance levels: 148.00.
Trading tips
If the price consolidates above the resistance level of 148.00, one may consider buying the company's stock. Potential profits should be locked in by orders at 151.00, 154.00, and 156.00. Stop loss – 145.00.
If the price consolidates below 144.00, #JNJ shares are expected to correct. The moving potential is aimed at the area of 138.00-136.00. Stop loss – 147.00.
Implementation period: 3 days.
No comments:
Write comments